deltatrials
Recruiting PHASE2 INTERVENTIONAL 4-arm NCT03803787

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Non-small Cell Lung Cancer Patients

Sponsor: Instituto Nacional de Cancerologia de Mexico

Conditions Radiation Pneumonitis
Interventions Inhaled budesonide
Updated 10 times since 2019 Last updated: Apr 29, 2025 Started: Sep 1, 2018 Primary completion: Dec 1, 2025 Completion: Dec 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Radiation Pneumonitis and is currently actively recruiting participants. Instituto Nacional de Cancerologia de Mexico leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Mar 2023 · 24 months · monthly snapshotRecruiting~Mar 2023 – ~May 2023 · 2 months · monthly snapshotUnknown Status~May 2023 – ~Dec 2023 · 7 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotRecruiting~Nov 2024 – ~Jun 2025 · 7 months · monthly snapshotRecruiting~Jun 2025 – present · 13 months · monthly snapshotRecruiting

Change History

10 versions recorded

  1. Jun 2025 — Present [monthly]

    Recruiting PHASE2

  2. Nov 2024 — Jun 2025 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Dec 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 5 earlier versions

  1. May 2023 — Dec 2023 [monthly]

    Recruiting PHASE2

    Status: Unknown Status → Recruiting

  2. Mar 2023 — May 2023 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  3. Mar 2021 — Mar 2023 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  5. Feb 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto Nacional de Cancerologia de Mexico
  • Instituto Nacional de Enfermedades Respiratorias
Data source: Instituto Nacional de Cancerologia de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations